Posted by Toby on October 14, 1998, at 10:21:35
In reply to Re: Reboxetine (Edronax) , posted by Salvatore Condorelli on October 2, 1998, at 7:34:37
Just read a review of the clinical studies done on Reboxetine. No mention of urinary retention or sexual side effects. The most common side effects listed were increased sweating, blurred vision, insomnia, headache and dry mouth. The most effective doses were between 8 and 10 mg per day and this range had the fewest side effects. About 75% of patients had a greater than 50% decrease in depressive symptoms and many patients began to improve after only 10 days (much faster than most SSRI's). The longest trial reported on was 12 months and patients that responded to Reboxetine continued to respond over the entire 12 months.
poster:Toby
thread:192
URL: http://www.dr-bob.org/babble/19990501/msgs/876.html